Johnson & Johnson subsidiary Janssen Pharmaceutica has signed an advance purchase agreement with the African Vaccine Acquisition Trust (AVAT) to manufacture and deliver up to 220 million doses of its single-shot Covid-19 vaccine. The vaccines will be supplied to the African Union’s 55 member states by Q3 2021. Under the agreement, AVAT has an option to order an additional 180 million doses, for a total of up to 400 million doses by 2022.

British pharmaceutical giant GSK has signed an agreement with Novavax and the UK Government Vaccines Taskforce to support the production of up to 60 million doses of Novavax’s coronavirus vaccine, NVX-CoV2373, for use in the UK. GSK will provide its fill-finish site in Barnard Castle for the production of the vaccine. The UK government ordered the 60 million doses from Novavax under an advance purchase contract.

Russian Direct Investment Fund and Chinese biotech company Shenzhen Yuanxing Gene-tech have agreed to produce over 60 million doses of the Sputnik V Covid-19 vaccine in China, enough to vaccinate 30 million individuals. Commercial production of the vaccines is expected to begin in May 2021.